Kevin Outterson speaking at World Antimicrobial Resistance Congress

Kevin Outterson,  Professor, Boston University,  Executive Director, CARB-X 


What do you see as the biggest challenges facing the AMR space into 2022? 

Funding for the research companies is still quite limited. Many resources have been diverted to COVID, but we can’t neglect bacteria. We have great science, but struggle with the economics.


If you could wave a magic wand, what would you like to see occur in the coming year to further combat AMR? 

PASTEUR Act becomes law and the rest of the G7/20 follows suit.


What would you like to highlight about your work/your organization for this coming year? 

CARB-X has refined our investment strategy with a sustainable plan for the next decade. We hope to announce these updates later this year.


Do you have any predictions for the AMR space in 2022 and beyond? Any calls-to-action you’d like to highlight?  

1.27M people die each year from resistant bacterial infections which are on par with HIV, malaria, and TB. Governments need to recognize AMR as a top-tier global health threat.





To Sponsor Or Exhibit


Semen Sen
+1 646.619.1793



To Speak


Emma Goaley
+1 646.400.2576



Press & Media Partnerships


Ipek Coskun
+1 407.421.5818